abstract |
The present invention relates to novel compounds that are glycogen phosphorylase inhibitors and their use in the treatment of diabetes and other conditions associated therewith. Furthermore, the present invention relates to a pharmaceutical composition containing the compound and a method for preparing the compound and the pharmaceutical composition. [Selection figure] None |